Poor survival associated with NUAK1 overexpression in serous ovarian cancer may be explained by chemotherapy resistance

Overview

cited authors

Phippen, Neil T.; Bateman, Nicholas W.; Wang, Guisong; Hamilton, Chad A.; Maxwell, George L.; Darcy, Kathleen M.; Conrads, Thomas P.

Publication Date

August 1, 2015

webpage

Web of Science

published in

CANCER RESEARCH Journal

301 E Princeton St., Orlando, FL 32804 | FH.RAS@AdventHealth.com | 407-200-2901

The information on this website is not a substitute for examination, diagnosis, and medical care provided by a licensed and qualified health professional. Please consult your physician before undertaking any form of medical treatment and/or adopting any exercise program or dietary guidelines. If you think you may have a medical emergency, call your physician or 911 immediately. AdventHealth Research Institute reserves the right to add, remove or edit content on this page at its sole discretion.